Intracranial Vertebrobasilar Stenosis:Angioplasty and Follow-up

References

1. ↵
   Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial. Lancet 1996;348:633-638

   CrossRefPubMedWeb of Science
2. ↵
   The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997;42:857-865

   CrossRefPubMedWeb of Science
3. ↵
   Gorter JW, De Schryver EL, Algra A. Secondary prevention after ischemic cerebral infarct, the ESPRIT study: low dose anticoagulation, combined therapy with acetylsalicylic acid/dipyridamole or monotherapy with acetylsalicylic acid? Nervenarzt 1999;70:368-370

   PubMed
4. ↵
   Chimowitz MI, Kokkinos J, Strong J, et al. The warfarin-aspirin symptomatic intracranial disease study. Neurology 1995;45:1488-1493

   Abstract/FREE Full Text
5. ↵
   Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischemia. J Neurol Neurosurg Psychiatry 1996;60:197-199

   Abstract/FREE Full Text
6. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 1998;29:1389-1392

   Abstract/FREE Full Text
7. ↵
   Kwiatkowski TG, Libman RB. Emergency strategies. In: Welch KMA, Caplan LR, Reis DJ, Siesjö BK, Weir B, eds. Primer on Cerebrovascular Diseases. San Diego: Academic Press 1997;671-675
8. Helgason CM. Mechanisms of antiplatelet agents and the prevention of stroke. In: Welch KMA, Caplan LR, Reis DJ, Siesjö BK, Weir B, eds. Primer on Cerebrovascular Diseases. San Diego: Academic Press 1997;712-716
9. ↵
   Brückmann H, Ringelstein EB, H. B Zeumer H. Percutaneous transluminal angioplasty of the vertebral artery: a therapeutic alternative to operative reconstruction of proximal vertebral artery stenoses. J Neurol 1986;233:336-339

   CrossRefPubMedWeb of Science
10. ↵
    Higashida RT, Tsai FY, Halbach VV, Dowd CF, Hieshima GB. Transluminal angioplasty, thrombolysis, and stenting for extracranial and intracranial cerebral vascular disease. J Intervent Cardiol 1996;9:245-255

    CrossRef
11. ↵
    Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993;78:192-198

    CrossRefPubMedWeb of Science
12. ↵
    Clark WM, Barnwell SL, Nesbit G, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995;26:1200-1204

    Abstract/FREE Full Text
13. ↵
    Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997;18:1661-1668

    Abstract
14. Higashida RT, Hieshima GB, Halbach VV. Advances in the treatment of complex cerebrovascular disorders by interventional neurovascular techniques. Circulation 1991;83: (Suppl I) 196-206
15. ↵
    Yokote H, Terada T, Ryujin K, et al. Percutaneous transluminal angioplasty for intracranial arteriosclerotic lesions. Neuroradiology 1998;40:590-596

    CrossRefPubMedWeb of Science
16. Callahan ASI, Berger BL. Balloon angioplasty of intracranial arteries for stroke prevention. J Neuroimaging 1997;7:232-235

    PubMedWeb of Science
17. ↵
    Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065-1069

    Abstract/FREE Full Text
18. ↵
    Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology 1997;39:111-116

    CrossRefPubMedWeb of Science
19. Higashida RT, Tsai FY, Halbach VV, Barnwell SL, Dowd CF, Hieshima GB. Interventional neurovascular techniques in the treatment of stroke: state-of-the-art therapy. J Intern Med 1995;237:105-115

    CrossRefPubMedWeb of Science
20. ↵
    Higashida RT, Tsai FY, Halbach VV, Dowd CF, Hieshima GB. Cerebral percutaneous transluminal angioplasty. Heart Dis Stroke 1993;2:497-502

    PubMed
21. ↵
    Akins PT, K PT, Cross DT, Moran CJ. Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke 1998;29:433-438

    Abstract/FREE Full Text
22. ↵
    Hopkins LN, Budny JL. Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg 1989;70:207-211

    CrossRefPubMedWeb of Science
23. ↵
    Sundt TM, Smith HC, Campbell JK, Vliestra RE, Cucchiera RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980;55:673-680

    PubMedWeb of Science
24. Houdart E, Ricolfi F, Brugières P, Antoine JC, Gaston A. Percutaneous transluminal angioplasty of atherosclerotic basilar artery stenosis. Neuroradiology 1996;38:383-385

    CrossRefPubMedWeb of Science
25. Connors III JJ, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999;91:415-423

    CrossRefPubMedWeb of Science
26. Nomura M, Hashimoto N, Nishi S, Akiyama Y. Percutaneous transluminal angioplasty for intracranial vertebral and/or basilar artery stenosis. Clin Radiol 1999;54:521-527

    PubMed
27. ↵
    Morris PP, Martin EM, Regan J, Braden G. Intracranial deployment of coronary stents for symptomatic atherosclerotic disease. AJNR Am J Neuroradiol 1999;20:1688-1694

    Abstract/FREE Full Text
28. Feldman RL, Trigg L, Gaudier J, Galat J. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of an intracranial carotid artery stenosis. Cathet Cardiovasc Diagn 1996;84:883-887
29. Al-Mubarak N, Gomez CR, Vitek JJ, Roubin GS. Stenting of symptomatic stenosis of the intracranial internal carotid artery. AJNR Am J Neuroradiol 1998;19:1949-1951

    Abstract
30. Mori T, Kazita K, Mori K. Cerebral angiography and stenting for intracranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol 1999;20:787-789

    Abstract/FREE Full Text
31. ↵
    Gomez CR, Misra VK, W LM, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95-99

    Abstract/FREE Full Text
32. ↵
    Malek AM, Higashida RT, Halbach VV, Phatouros CC, Meyers PM, Dowd CF. Tandem intracranial stent deployment for treatment of an iatrogenic, flow-limiting, basilar artery dissection: technical case report. Neurosurgery 1999;45:919-924

    CrossRefPubMedWeb of Science
33. ↵
    Gorter JW, for the Stroke Prevention in Reversible Ischemia Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) Study Groups. Major bleeding during anticoagulation after cerebral ischemia: pattern and risk factors. Neurology 1999;53:1319-1327

    Abstract/FREE Full Text
34. ↵
    International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke. Lancet 1997;349:1569-1581

    CrossRefPubMedWeb of Science
35. Ahuja A, Guterman LR, Hopkins LN. Angioplasty for basilar artery atherosclerosis. J Neurosurg 1992;77:941-944

    CrossRefPubMedWeb of Science
36. Terada T, Higashida RT, Halbach VV, et al. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatry 1996;60:377-381

    Abstract/FREE Full Text